Sanjivani Paranteral Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531569
₹167.00
▼ -4.70 (-2.74%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
76/100
Strong
Valuation
35/100
Fairly Valued
Momentum
29/100
Bearish

QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹205 Cr
PE (TTM)
27.2
Industry median 36.1 (152 companies)
Price to Book
4.0
PEG (TTM)
-2.5
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-56.2
Free Cash Flow
₹-9 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
28.08%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
0.76%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-7.30%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
37.88%
as of Dec. 31, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
8.75%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.38
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.28
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
20.97
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
12.54%
as of Dec. 31, 2025
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
16.66%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
15.82%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
10.43%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
17.19%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
16.91%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.28)
  • Yes Return on equity is 15% or more (16.9%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.7%
Low 163.0000 · High 173.8000
1W return
-3.4%
Low 163.0000 · High 174.9000
1M return
-13.2%
Low 163.0000 · High 202.5000
52W return
-56.2%
Low 163.0000 · High 213.7500
Lifetime High ₹381.2000 (Dec. 24, 2024)
Lifetime Low ₹3.2800 (April 25, 2019)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
169.9
10D
172.7
20D
177.8
50D
184.5
100D
182.9
200D
171.4

Delivery and volume

Day avg. delivery
69.4%
Week avg. delivery
80.2%
Month avg. delivery
92.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

167.93
Pivot
First resistance172.87
Second resistance178.73
Third resistance183.67
First support162.07
Second support157.13
Third support151.27
Day RSI38.3
Day MFI14.0
Day MACD-6.36
Day MACD signal-5.68

Beta

1M-0.02
3M-0.06
1Y-0.06
3Y0.36

Price change analysis

↓ -13.2%
Over 1 Month
LowHigh
163.00202.50
↓ -56.2%
Over 3 Months
LowHigh
163.00213.75
↓ -56.2%
Over 6 Months
LowHigh
163.00213.75
↓ -56.2%
Over 1 Year
LowHigh
163.00213.75
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 27.2 (own history: 25.1–66.6)
Buy Zone
Revenue (June 30, 2026)
₹19 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹1.8700

Ranks #116 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter31.56%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 31.26% to 31.56% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
19 Feb 2025 MONIKA GARWARE Bulk Sell 227,509 243.4400 BSE
26 Aug 2024 NEXT ORBIT VENTURES FUND Bulk Sell 200,000 290.0000 BSE
22 Aug 2024 NEXT ORBIT VENTURES FUND Bulk Sell 100,000 280.4600 BSE
20 Dec 2023 SUREKHA HARAN Bulk Sell 101,034 152.7000 BSE
18 Sep 2023 SUREKHA HARAN Bulk Buy 50,000 100.0500 BSE
15 Sep 2023 SETU SECURITIES PVT. LTD. Bulk Buy 50,000 100.0600 BSE
12 Sep 2023 SUREKHA HARAN Bulk Buy 50,000 100.0000 BSE
27 Mar 2023 WOODSTOCK SECURITIES PRIV ATE LTD Bulk Sell 55,966 27.0200 BSE
24 Mar 2023 WOODSTOCK SECURITIES PRIV ATE LTD Bulk Sell 79,292 25.9400 BSE
20 Mar 2023 NEXT ORBIT VENTURES FUND Bulk Sell 60,000 32.7500 BSE

All bulk and block deals →

Corporate Announcements

All 3 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Sanjivani Paranteral Ltd - 531569 - Closure of Trading Window
16 Sep 2026 AGM/EGM Sanjivani Paranteral Ltd - 531569 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
16 Sep 2026 AGM/EGM Sanjivani Paranteral Ltd - 531569 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.28)
  • Comfortable interest coverage (21.0x)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 56.2% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Sanjivani Paranteral Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.